Roflumilast as a Potential Therapeutic Agent for Cecal Ligation and Puncture-Induced Septic Lung Injury.
Zafer BayraktutanBusra DincerHalil KeskinDuygu KoseArzu BilenErdem ToktayBusra SirinZekai HaliciPublished in: Journal of investigative surgery : the official journal of the Academy of Surgical Research (2021)
ROF, a PDE4 inhibitor, suppressed the expression levels of pro-inflammatory cytokines, alleviated lung damage (probably by blocking neutrophil infiltration), and increased the capacity of the antioxidant system.